Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Department of Traditional Chinese Medicine, Xianfeng County People's Hospital, Enshi, 445000, China.
Curr Med Sci. 2023 Aug;43(4):631-646. doi: 10.1007/s11596-023-2763-0. Epub 2023 Aug 10.
Cancer treatment has evolved rapidly due to major advances in tumor immunity research. However, due to the complexity, heterogeneity, and immunosuppressive microenvironment of tumors, the overall efficacy of immunotherapy is only 20%. In recent years, nanoparticles have attracted more attention in the field of cancer immunotherapy because of their remarkable advantages in biocompatibility, precise targeting, and controlled drug delivery. However, the clinical application of nanomedicine also faces many problems concerning biological safety, and the synergistic mechanism of nano-drugs with immunity remains to be elucidated. Our study summarizes the functional characteristics and regulatory mechanisms of nanoparticles in the cancer immune microenvironment and how nanoparticles activate and long-term stimulate innate immunity and adaptive immunity. Finally, the current problems and future development trends regarding the application of nanoparticles are fully discussed and prospected to promote the transformation and application of nanomedicine used in cancer treatment.
由于肿瘤免疫研究的重大进展,癌症治疗得到了迅速发展。然而,由于肿瘤的复杂性、异质性和免疫抑制微环境,免疫疗法的总体疗效仅为 20%。近年来,由于纳米粒子在生物相容性、精确靶向和药物控释方面具有显著优势,在癌症免疫治疗领域引起了更多关注。然而,纳米医学的临床应用也面临着许多关于生物安全性的问题,纳米药物与免疫的协同机制仍有待阐明。我们的研究总结了纳米粒子在癌症免疫微环境中的功能特性和调节机制,以及纳米粒子如何激活和长期刺激固有免疫和适应性免疫。最后,充分讨论了纳米粒子应用中存在的问题和未来的发展趋势,以促进癌症治疗用纳米医学的转化和应用。